NM_000051.4:c.6808-60_6808-58delATT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000051.4(ATM):​c.6808-60_6808-58delATT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.55 in 1,535,810 control chromosomes in the GnomAD database, including 237,239 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 20285 hom., cov: 0)
Exomes 𝑓: 0.56 ( 216954 hom. )

Consequence

ATM
NM_000051.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.05

Publications

1 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-108325985-CATT-C is Benign according to our data. Variant chr11-108325985-CATT-C is described in ClinVar as [Benign]. Clinvar id is 633055.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATMNM_000051.4 linkc.6808-60_6808-58delATT intron_variant Intron 46 of 62 ENST00000675843.1 NP_000042.3 Q13315A0A024R3C7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATMENST00000675843.1 linkc.6808-72_6808-70delATT intron_variant Intron 46 of 62 NM_000051.4 ENSP00000501606.1 Q13315

Frequencies

GnomAD3 genomes
AF:
0.501
AC:
75883
AN:
151486
Hom.:
20272
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.300
Gnomad AMI
AF:
0.642
Gnomad AMR
AF:
0.608
Gnomad ASJ
AF:
0.640
Gnomad EAS
AF:
0.414
Gnomad SAS
AF:
0.602
Gnomad FIN
AF:
0.629
Gnomad MID
AF:
0.731
Gnomad NFE
AF:
0.567
Gnomad OTH
AF:
0.544
GnomAD4 exome
AF:
0.556
AC:
769167
AN:
1384206
Hom.:
216954
AF XY:
0.559
AC XY:
386533
AN XY:
691182
show subpopulations
African (AFR)
AF:
0.293
AC:
9318
AN:
31842
American (AMR)
AF:
0.629
AC:
26873
AN:
42714
Ashkenazi Jewish (ASJ)
AF:
0.612
AC:
15583
AN:
25452
East Asian (EAS)
AF:
0.415
AC:
16153
AN:
38952
South Asian (SAS)
AF:
0.598
AC:
49650
AN:
83066
European-Finnish (FIN)
AF:
0.626
AC:
31549
AN:
50426
Middle Eastern (MID)
AF:
0.713
AC:
3741
AN:
5244
European-Non Finnish (NFE)
AF:
0.557
AC:
584530
AN:
1048768
Other (OTH)
AF:
0.550
AC:
31770
AN:
57742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
16817
33633
50450
67266
84083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15972
31944
47916
63888
79860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.501
AC:
75916
AN:
151604
Hom.:
20285
Cov.:
0
AF XY:
0.509
AC XY:
37683
AN XY:
74028
show subpopulations
African (AFR)
AF:
0.300
AC:
12418
AN:
41354
American (AMR)
AF:
0.608
AC:
9252
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.640
AC:
2221
AN:
3468
East Asian (EAS)
AF:
0.414
AC:
2136
AN:
5158
South Asian (SAS)
AF:
0.603
AC:
2900
AN:
4808
European-Finnish (FIN)
AF:
0.629
AC:
6587
AN:
10480
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.567
AC:
38461
AN:
67818
Other (OTH)
AF:
0.545
AC:
1146
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1851
3702
5554
7405
9256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.527
Hom.:
2658
Bravo
AF:
0.489
Asia WGS
AF:
0.533
AC:
1852
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 09, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The ATM c.6808-60_6808-58delATT variant involves the deletions of a stretch of three intronic nucleotides. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in gnomAD in 15100/30750 control chromosomes at a frequency of 0.4910569, which is approximately 124 times the estimated maximal expected allele frequency of a pathogenic ATM variant (0.0039528), suggesting this variant is a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 80% of patients studied by a panel of primary immunodeficiencies. Number of patients: 76. Only high quality variants are reported. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Ataxia-telangiectasia syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212322; hg19: chr11-108196712; COSMIC: COSV107218861; COSMIC: COSV107218861; API